Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors

Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors

US Patent 11945870 · Granted Apr 2, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Immunostimulatory agents in combination with angiogenesis inhibitors2023
Immunostimulatory agents in combination with angiogenesis inhibitors2023
Immunostimulatory agents in combination with angiogenesis inhibitors2023
Compositions and methods for modulating IL-10 immunostimulatory and anti-inflamm2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2022
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2022